CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −3,279 | $534.21 | $1.8M | 47,812 |
| 2026-07-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,041 | $535.88 | $558K | 46,771 |
| 2026-07-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,519 | $534.99 | $813K | 45,252 |
| 2026-07-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −80 | $536.85 | $43K | 45,172 |
| 2026-07-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise · Stock Option 10b5-1 | −8,300 | 80,740 | ||
| 2026-07-15 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +1,718 | $135.42 | $233K | 42,231 |
| 2026-07-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $521.82 | $42K | 42,151 |
| 2026-07-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $523.97 | $63K | 42,031 |
| 2026-07-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $525.43 | $42K | 41,951 |
| 2026-07-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $527.55 | $21K | 41,911 |
| 2026-07-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $529.66 | $64K | 41,791 |
| 2026-07-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −278 | $530.97 | $148K | 41,513 |
| 2026-07-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −800 | $532.06 | $426K | 40,713 |
| 2026-07-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $533.22 | $85K | 40,553 |
| 2026-07-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $534.09 | $21K | 40,513 |
| 2026-07-15 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +7,782 | $135.42 | $1.1M | 332,225 |
| 2026-07-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −48 | $520.92 | $25K | 332,177 |
| 2026-07-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −189 | $521.84 | $99K | 331,988 |
| 2026-07-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −203 | $523.20 | $106K | 331,785 |
| 2026-07-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −440 | $524.40 | $231K | 331,345 |
Page 67 of 121 · 2,404 trades